Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017

GlobalData, April 2011, Pages: 79

Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017

Summary

GlobalData’s new report, “Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global cardiac markers market. The report provides market landscape, competitive landscape and market trends information on the cardiac markers market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within cardiac markers market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthcare, Alere and Beckman Coulter.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the cardiac markers market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the cardiac markers market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global cardiac markers market and the factors shaping it.

1 Table of contents
1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Report Guidance
3 Cardiovascualr Disease Overview
3.1 Pathophysiology
3.2 Disease Burden
3.3 Diagnosis
4 Cardiac Markers: Market Characterization
4.1 Cardiac Markers Market, Global, Revenue ($m), Historic, 2003-2010
4.2 Cardiac Markers Market, Global, Revenue ($m), Forecast, 2010-2017
4.3 Cardiac Markers, Key Trends
4.3.1 Lab-on--a Chip Cardiac Sensor System
4.3.2 Use of Predictive Markers for Personalized Treatment
4.3.3 High-Sensitivity CRP (hs-CRP)
4.3.4 Heart-Type Fatty Acid Binding Protein (H-FABP)
4.3.5 Cardiac Biomarker Soluble ST2 (sST2) Exhibits Significant Clinical Value
4.3.6 Myeloperoxidase (MPO)
4.3.7 Brain Natriuretic Peptide (BNP)
4.4 Cardiac Markers, Market Dynamics
4.4.1 Cardiac Markers, Market Drivers
4.4.2 Cardiac Markers Market Restraints
5 Global Cardiac Markers Market, by Country, Revenue ($m), 2003-2017
5.1 Cardiac Markers Market, the US, Revenue ($m), Historic, 2003 – 2010
5.2 Cardiac Markers Market, the US, Revenue ($m), Forecast, 2010 – 2017
5.3 Cardiac Markers Market, Canada, Revenue ($m), Historic, 2003 – 2010
5.4 Cardiac Markers Market, Canada, Revenue ($m), Forecast, 2010 – 2017
5.5 Cardiac Markers Market, the UK, Revenue ($m), Historic, 2003 – 2010
5.6 Cardiac Markers Market, the UK, Revenue ($m), Forecast, 2010 – 2017
5.7 Cardiac Markers Market, Germany, Revenue ($m), Historic, 2003 – 2010
5.8 Cardiac Markers Market, Germany, Revenue ($m), Forecast, 2010 – 2017
5.9 Cardiac Markers Market, France, Revenue ($m), Historic, 2003 – 2010
5.10 Cardiac Markers Market, France, Revenue ($m), Forecast, 2010 – 2017
5.11 Cardiac Markers Market, Italy, Revenue ($m), Historic, 2003 – 2010
5.12 Cardiac Markers Market, Italy, Revenue ($m), Forecast, 2010 – 2017
5.13 Cardiac Markers Market, Spain, Revenue ($m), Historic, 2003 – 2010
5.14 Cardiac Markers Market, Spain, Revenue ($m), Forecast, 2010 – 2017
5.15 Cardiac Markers Market, Japan, Revenue ($m), Historic, 2003 – 2010
5.16 Cardiac Markers Market, Japan, Revenue ($m), Forecast, 2010 – 2017
5.17 Cardiac Markers Market, China, Revenue ($m), Historic, 2003 – 2010
5.18 Cardiac Markers Market, China, Revenue ($m), Forecast, 2010 – 2017
5.19 Cardiac Markers Market, India, Revenue ($m), Historic, 2003 – 2010
5.20 Cardiac Markers Market, India, Revenue ($m), Forecast, 2010 – 2017
5.21 Cardiac Markers Market, Australia, Revenue ($m), Historic, 2003 – 2010
5.22 Cardiac Markers Market, Australia, Revenue ($m), Forecast, 2010 – 2017
5.23 Cardiac Markers Market, Brazil, Revenue ($m), Historic, 2003-2010
5.24 Cardiac Markers Market, Brazil, Revenue ($m), Forecast, 2010 – 2017
6 Cardiac Markers Market: Strategic Competitive Assessment
6.1 Cardiac Markers Market, Global, Company Share (%), 2010
6.2 Cardiac Markers Market, Competitive Analysis
6.2.1 Threat of Rivalry
6.2.2 Threat of New Entrants
6.2.3 Buyer Power
6.2.4 Threat of Substitute
6.2.5 Supplier Power
6.3 Cardiac Markers: Key Market Participants
6.3.1 F. Hoffmann-La Roche Ltd.
6.3.2 Abbott Laboratories
6.3.3 Siemens Healthcare
6.3.4 Alere
6.3.5 Beckman Coulter, Inc.
7 Key Marketed Cardiac Markers
7.1 TROP T Sensitive Rapid Assay
7.1.1 Product Description
7.1.2 Features and Benefits
7.2 Cobas c 111 Analyzer
7.2.1 Product Description
7.2.2 Features and Benefits
7.3 I-STAT System
7.3.1 Product Description
7.3.2 Features and Benefits
7.4 Stratus CS Analyzer
7.4.1 Product Description
7.4.2 Features and Benefits
7.5 TriageBNP
7.5.1 Product Description
7.5.2 Features and Benefits
8 Cardiac Markers Market: Strategic Pipeline Assessment
8.1 Device Pipeline Products Summary
8.2 Profiles of Promising Products Under Clinical Development
8.2.1 VASCLIR
8.2.2 ARCHITECT MPO ASSAY
8.2.3 CADPrint
8.2.4 Presage ST2 Assay
8.2.5 Verigene Cardiac Troponin I Assay
8.2.6 Lab-on-a -Film Cardiac Sensor System
9 Cardiac Marker Market: Strategic Deals Analysis
9.1 Key Acquisitions
9.1.1 Danaher to Acquire Beckman Coulter
9.1.2 bioMerieux Completed the Acquisition of Meikang Biotech (Shanghai)
9.1.3 Inverness Medical Innovations Acquired 78.13% Stake in Standard Diagnostics
9.1.4 VaxGen Completed Acquisition of diaDexus
9.1.5 Siemens Medical Solutions Acquired Dade Behring
9.2 Key Partnerships
9.2.1 BG Medicine Enters Into an Agreement with Siemens Healthcare Diagnostics
9.2.2 Axis-Shield Signs Option Agreement with Bio-Rad Laboratories
10 Appendix
10.1 Definitions
10.1.1 Cardiac Markers
10.2 Acronyms
10.3 Sources
10.4 Research Methodology
10.5 Secondary Research
10.6 Primary Research
10.7 Models
10.8 Forecasts
10.9 Expert Panels
10.10 Consulting
10.11 Contact Us
10.12 Disclaimer

1.1 List of Tables
Table 1: Cardiac Markers Market, Global, Revenue ($m), 2003-2010
Table 2: Cardiac Markers Market, Global, Revenue ($m), 2010- 2017
Table 3: Pipeline hs-CRP Cardiac Markers
Table 4: Pipeline MPO Cardiac Markers
Table 5: Commercial POC Testing for Cardiac Markers
Table 6: Cardiac Markers Market, the US, Revenue ($m), 2003-2010
Table 7: Cardiac Markers Market, the US, Revenue ($m), 2010-2017
Table 8: Cardiac Markers Market, Canada, Revenue ($m), 2003-2010
Table 9: Cardiac Markers Market, Canada, Revenue ($m), 2010-2017
Table 10: Cardiac Markers Market, the UK, Revenue ($m), 2003-2010
Table 11: Cardiac Markers Market, the UK, Revenue ($m), 2010-2017
Table 12: Cardiac Markers Market, Germany, Revenue ($m), 2003-2010
Table 13: Cardiac Markers Market, Germany, Revenue ($m), 2010-2017
Table 14: Cardiac Markers Market, France, Revenue ($m), 2003-2010
Table 15: Cardiac Markers Market, France, Revenue ($m), 2010-2017
Table 16: Cardiac Markers Market, Italy, Revenue ($m), 2003-2010
Table 17: Cardiac Markers Market, Italy, Revenue ($m), 2010-2017
Table 18: Cardiac Markers Market, Spain, Revenue ($m), 2003-2010
Table 19: Cardiac Markers Market, Spain, Revenue ($m), 2010-2017
Table 20: Cardiac Markers Market, Japan, Revenue ($m), 2003-2010
Table 21: Cardiac Markers Market, Japan, Revenue ($m), 2010-2017
Table 22: Cardiac Markers Market, China, Revenue ($m), 2003-2010
Table 23: Cardiac Markers Market, China, Revenue ($m), 2010-2017
Table 24: Cardiac Markers Market, India, Revenue ($m), 2003-2010
Table 25: Cardiac Markers Market, India, Revenue ($m), 2010-2017
Table 26: Cardiac Markers Market, Australia, Revenue ($m), 2003-2010
Table 27: Cardiac Markers Market, Australia, Revenue ($m) , 2010-2017
Table 28: Cardiac Markers Market, Brazil, Revenue ($m), 2003-2010
Table 29: Cardiac Markers Market, Brazil, Revenue ($m), 2010-2017
Table 30: Cardiac Markers Market, Global, Key Company Revenue ($m), 2010
Table 31: F. Hoffman-La-Roche, Marketed Products, 2010
Table 32: F. Hoffman-La-Roche, Pipeline Products, 2010
Table 33: Abbott Laboratories, Marketed Products
Table 34: Abbott Laboratories, Pipeline Products
Table 35: Siemens Healthcare, Marketed Products, 2010
Table 36: Siemens Healthcare, Pipeline Products, 2010
Table 37: Beckman Coulter, Inc, Marketed Products
Table 38: Beckman Coulter Inc, Pipeline Products, 2010
Table 39: TROP T Sensitive Rapid Assay, Features and Benefits
Table 40: Cobas c 111 Analyzer, Features and Benefits
Table 41: i-STAT System, Features and Benefits
Table 42: Stratus CS Analyzer, Features and Benefits
Table 43: TriageBNP, Features and Benefits
Table 44: Cardiac Markers Market, Global, Pipeline Products
Table 45: Cardiac Markers Market, List of Pipeline Products in Clinical Development
Table 46: Cardiac Markers Market, List of Pipeline Products in Early Development
Table 47: Cardiac Markers Market, List of Pipeline Products
Table 48: VASCLIR, Product Status, 2010
Table 49: VASCLIR, Clinical Trials, 2010
Table 50: ARCHITECT MPO ASSAY, Product Status, 2010
Table 51: Architect MPO Assay, Clinical Trials, 2010
Table 52: CADPrint, Product Status, 2010
Table 53: CADPrint, Clinical Trials, 2010
Table 54: PresageAssay ST2, Product Status, 2010
Table 55: PresageAssay ST2, Clinical Trial, 2010
Table 56: Verigene Cardiac Troponin I Assay, Product Status, 2010
Table 57:Verigene Cardiac Troponin I Assay, Clinical Trial, 2010
Table 58:Lab-on-a Film Cardiac Sensor System, Product Status

1.2 List of Figures
Figure 1: Cardiovascular Diseases, Pathphysiology
Figure 2: Cardiovascular Disease Burden, Global, 2010
Figure 3: Cardiac Markers Market, Global, Revenue ($m), 2003-2010
Figure 4: Cardiac Markers Market, Global, Revenue ($m), 2010- 2017
Figure 5: Diagnostic Work Flow Diagram for Underlying Personalized Medicine
Figure 6: Cardiac Markers Market, Global, Market Dynamics
Figure 7: Cardiac Markers Market, the US, Revenue ($m), 2003-2010
Figure 8: Cardiac Markers Market, the US, Revenue ($m), 2010-2017
Figure 9: Cardiac Markers Market, Canada, Revenue ($m), 2003-2010
Figure 10: Cardiac Markers Market, Canada, Revenue ($m), 2010-2017
Figure 11: Cardiac Markers Market, the UK, Revenue ($m), 2003-2010
Figure 12: Cardiac Markers Market, the UK, Revenue ($m), 2010-2017
Figure 13: Cardiac Markers Market, Germany, Revenue ($m), 2003-2010
Figure 14: Cardiac Markers Market, Germany, Revenue ($m), 2010-2017
Figure 15: Cardiac Markers Market, France, Revenue ($m), 2003-2010
Figure 16: Cardiac Markers Market, France, Revenue ($m), 2010-2017
Figure 17: Cardiac Markers Market, Italy, Revenue ($m), 2003-2010
Figure 18: Cardiac Markers Market, Italy, Revenue ($m), 2010-2017
Figure 19: Cardiac Markers Market, Spain, Revenue ($m), 2003-2010
Figure 20: Cardiac Markers Market, Spain, Revenue ($m), 2010-2017
Figure 21: Cardiac Markers Market, Japan, Revenue ($m), 2003-2010
Figure 22: Cardiac Markers Market, Japan, Revenue ($m), 2010-2017
Figure 23: Cardiac Markers Market, China, Revenue ($m), 2003-2010
Figure 24: Cardiac Markers Market, China, Revenue ($m), 2010-2017
Figure 25: Cardiac Markers Market, India, Revenue ($m), 2003-2010
Figure 26: Cardiac Markers Market, India, Revenue ($m), 2010-2017
Figure 27: Cardiac Markers Market, Australia, Revenue ($m), 2003-2010
Figure 28: Cardiac Markers Market, Australia, Revenue ($m), 2010-2017
Figure 29: Cardiac Markers Market, Brazil, Revenue ($m), 2003-2010
Figure 30: Cardiac Markers Market, Brazil, Revenue ($m), 2010-2017
Figure 31: Cardiac Markers Market, Global, Key Company Share, 2010
Figure 32: Cardiac Markers Market, Competitive Analysis
Figure 33: F. Hoffman-La-Roche, SWOT Analysis
Figure 34: Abbott, SWOT Analysis
Figure 35: Siemens, SWOT Analysis
Figure 36: Alere, SWOT Analysis
Figure 37: Beckman Coulter, SWOT Analysis
Figure 38: Cardiac Markers Market, Global, Pipeline Products

“Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017” provides key data, information and analysis on the global cardiac markers market. The report provides market landscape, competitive landscape and market trends information on the cardiac markers market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Global Cardiac Markers Market is Forecast to Exceed $1 billion by 2017

The global cardiac markers market is forecast to exceed $1 billion by 2017, growing at a Compound Annual Growth Rate (CAGR) of 6% during 2010-2017. The global cardiac markers market expects to grow due to increasing incidence of cardiovascular diseases. The market is also expected to be driven by increased emphasis on Point of care testing (POCT), new and innovative products in the pipeline and cost-cutting measures such as laboratory automation. Increasing awareness of early detection and screening of cardiovascular diseases is also contributing to the growth of cardiac markers market.

US is the Biggest Cardiac Markers Market

The US is the biggest market for cardiac markers. The US market was valued at $209m in 2010 and expected to grow at a CAGR of 6% to reach $320.6m in 2017, contributing 30% towards the global cardiac markers market. The market is expected to receive a boost from the recent advancements in the field of cardiac marker analysers. However the market is focusing towards cost-effective diagnostic tests because of the market’s low reimbursement level and rising pressure on the healthcare infrastructure to reduce the prices of the testing. Thus, POCT is increasingly used in order to reduce the cost of diagnosis, time of intervention and the number of patients admitted to coronary care units.

Roche is the Leader in the Global Cardiac Markers Market

F.Hoffmann-La Roche, Abbott Laboratories, Siemens, Alere and Beackman Coulter were the leading companies in the cardiac markers market in 2010. These top companies accounted for 66% of the market. Roche was the market leader with a 21% share of the market and is expected to maintain its leadership position in the future with a strong pipeline of products.

The global market for cardiac markers is quite fragmented due to the presence of a number of small players. However, a large number of acquisitions of the smaller players by the market leaders is resulting in the consolidation of the market.

F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Siemens Healthcare
Alere
Beckman Coulter, Inc.

Customers who bought this item also bought

• Cardiac Biomarkers - Global Strategic Business Report
• Cardiac Defibrillators - Global Strategic Business Report
• Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
• Cardiac Rhythm Management (CRM) Devices - Global Strategic Business Report
• Medical Nutrition - A Global Market Overview
• Diabetes Diagnostics - Global Strategic Business Report
• Biomarkers - Global Strategic Business Report
• Gamma/Scintillation Cameras - Global Strategic Business Report
• Cholesterol & Other Cardiovascular Testing - Global Strategic Business Report
• Medical Ultrasound Equipment - Global Strategic Business Report